|
⚲
|
| Keyboard |
| Veradermics Inc | |
|---|---|
| Ticker | MANE |
| CIK # | 0001827635 |
| CUSIP | 922967104 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 470 James Street, New Haven, CT 06513 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Veradermics Inc | 2025-10-28 | 135.0 M | Exemption: 506(b) · Remaining: $15,000,000 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001827635] | 10-K | |
| [0001827635] | 10-Q | |
| [0001827635] | 3 | |
| [0001827635] | 4 | |
| [0001827635] | 8-K | |
| [0001827635] | D | |
| [0001827635] | SC 13D | |
| [0001827635] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Citadel Advisors LLC | Veradermics Inc | [2026-05-07] | 0.0 |
| Seven Fleet Capital Management LP | Veradermics Inc | [2026-05-05] | 0.0 |
| Viking Global Investors LP | Veradermics Inc | [2026-02-12] | 0.0 |
| Longitude Capital Partners V LLC | Veradermics Inc | [2026-02-12] | 0.0 |
| SR One Capital Management LLC | Veradermics Inc | [2026-02-11] | 0.0 |
| Suvretta Capital Management LLC | Veradermics Inc | [2026-02-11] | 0.0 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Averill Master Fund Ltd +3
Common stock, par value $0.00001 per share
|
2026-02-06 | Buy | 19,338 | $36.55 | 706,804 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.00001 per share
|
2026-02-06 | Buy | 11,183 | $35.97 | 402,253 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.00001 per share
|
2026-02-05 | Buy | 19,199 | $36.93 | 709,019 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.00001 per share
|
2026-02-05 | Buy | 38,771 | $37.63 | 1,458,953 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.00001 per share
|
2026-02-05 | Buy | 17,835 | $38.67 | 689,679 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.00001 per share
|
2026-02-05 | Buy | 16,563 | $39.80 | 659,207 |
|
Coric Vlad
Series C Convertible Preferred Stock · derivative
|
2026-02-05 | Conversion | 78,075 | ||
|
Averill Master Fund Ltd +3
Common stock, par value $0.00001 per share
|
2026-02-05 | Buy | 3,832 | $36.07 | 138,220 |
|
Enright Patrick G
Common Stock
|
2026-02-05 | Conversion | 1,171,121 | ||
|
Enright Patrick G
Common Stock
|
2026-02-05 | Buy | 192,647 | $17.00 | 3,274,999 |
|
Durso Timothy August
Common Stock
|
2026-02-05 | Conversion | 1,473 | ||
|
Waldman Reid Alexander
Common Stock
|
2026-02-05 | Conversion | 1,437 | ||
|
Grant-Kels Jane M
Series A Convertible Preferred Stock · derivative
|
2026-02-05 | Conversion | 2,455 | ||
|
Coric Vlad
Series C Convertible Preferred Stock · derivative
|
2026-02-05 | Conversion | 117,112 | ||
|
Coric Vlad
Series C Convertible Preferred Stock · derivative
|
2026-02-05 | Conversion | 78,075 | ||
|
Coric Vlad
Series B Convertible Preferred Stock · derivative
|
2026-02-05 | Conversion | 148,794 | ||
|
Coric Vlad
Series B Convertible Preferred Stock · derivative
|
2026-02-05 | Conversion | 148,794 | ||
|
Coric Vlad
Series A Convertible Preferred Stock · derivative
|
2026-02-05 | Conversion | 33,706 | ||
|
Coric Vlad
Series A Convertible Preferred Stock · derivative
|
2026-02-05 | Conversion | 33,706 | ||
|
Common Stock
|
2026-02-05 | Buy | 294,117 | $17.00 | 4,999,989 |
| showing 20 of 76 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 81 | 26,054,357 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| MassMutual Private Wealth & Trust FSB | [2026-06-30] | SOLE | 72 | 72 |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 13 | 13 |
| Physician Wealth Advisors Inc | [2026-06-30] | SOLE | 0 | 7 |
| Gamma Investing LLC | [2026-06-30] | DFND | 2 | 2 |
| Hughes Financial Services LLC | [2026-06-30] | SOLE | 1 | 1 | Prev | Page 1 | Next |